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226 Resting energy expenditure and nutritional status pre and post
lung transplantation
D. Kalnins1, M. Solomon1,2, H. Grasemann1,2, P.B. Pencharz1,2. 1The Toronto
Lung Transplant Program, The Hospital for Sick Children, Toronto, ON, Canada;
2The University of Toronto, Toronto, ON, Canada
Elevated resting energy expenditure (REE) is observed in patients with cystic
ﬁbrosis (CF) awaiting lung transplantation. Our own results conﬁrm this; REE was
133±12% of predicted in 15 patients (mean age 13.4±2.9, 10 females) awaiting
lung transplant. In order to determine if there was any change in energy requirements
post lung transplant, REE was measured using Indirect Calorimetry (IC) in patients
with CF pre and post lung transplant.
IC was performed in 7 patients (5 males) with CF before and after lung transplant
(mean age 12.0±3.2, range 7.1−16.2 years). Nutritional status was deﬁned by
percent ideal body weight (%IBW). Six of the 7 patients received gastrostomy
tube feeding nightly for nutritional support, pre transplant.
REE was 141±9% (range 129–159%) pre lung transplant and 121±14% (range
104–145%) post transplant, which was signiﬁcantly different, p< 0.002 (paired
t-test). The mean decline in REE was 20±10% (range 4−32). IC was performed
10.1±8.5 months pre and 5.7±6.9 months post transplant. The mean % IBW was
93±7.1% and 92±9.6% pre and post transplant, respectively.
Summary and Conclusions: In patients with CF, REE was elevated pre lung
transplant and remained elevated post transplant, however REE declined in all
patients. Patients were fairly well nourished pre and post lung transplant. Oral
intake is often supplemented with enteral feeds pre and post transplant and in some
cases, parenteral nutrition post transplant may be required until enteral tolerance is
achieved. We recommend leaving enteral tube feedings in place at least 6 months
post transplant as energy requirements appear to remain elevated, at least in this
small group of pediatric patients with CF.
227 Validity of the Tanita TBF-300M body composition analyser in
children with cystic ﬁbrosis
R.M. van Oversteeg1, J.W. Woestenenk2,3, N.M. de Roos2, P.J. Hulshof1,
C.K. van der Ent3. 1Division of Human Nutrition, Wageningen UR, Wageningen,
Netherlands; 2Department of Dietetics and Nutritional Sciences, Julius Centre for
Health Sciences and Primary Care, Utrecht, Netherlands; 3Cystic Fibrosis Centre,
Utrecht, Netherlands
Objective: The purpose of this study was to validate the Tanita body composition
analyser, a non-invasive technique for measuring body composition in children with
CF.
Design: We compared estimates of body fat percentage (BF%) measured with
the Tanita analyser (Tanita TBF-300M) with BF% measured by air displacement
plethysmography (ADP; Bodpod, Life measurements Inc), the best available refer-
ence method for this population, validated in children against hydrostatic weighing
in our laboratory at Wageningen University.
Subjects: Measurements were performed in 36 patients with CF during their visit
at our outpatient clinic (15 boys, 21 girls, aged 7−17 y, BMI range 13.722.5).
Results: BF% measured in the Bodpod ranged from 6.4−34.5% with a mean of
17.4%. BF% measured with the Tanita ranged from 2.9−27.0% with a mean of
15.9%. Bland-Altman analysis showed that Tanita values of BF% were on average
1.5% lower than Bodpod values (95% limits of agreement = −14.3 to 11.3%, p for
difference 0.170). The difference between the two methods was independent of the
magnitude of BF% (r = −0.052, p = 0.764).
Conclusion: For groups, the Tanita body composition analyser can be used to
estimate body fat percentage in children and adolescents with CF because the mean
difference with the Bodpod was small and not signiﬁcant. However, for individual
patients data should be used with caution.
228 The value of a non-invasive method to assess fat free mass
in adult CF patients – correlation with outcome measures in a
cohort of adult CF patients
J. Al Siaidi, N.A. Jarad. Adult CF Centre, Bristol Royal Inﬁrmary, Bristol, United
Kingdom
Background: Bioelectrical impedance analysis (BIA) is a rapid, portable, non-
invasive method of estimating body composition. Fat Free Mass (FFM) can be
calculated from BIA values. The relationship between FFM and recognised outcome
measures in a cohort of adult CF patients was investigated.
Patients and Methods: A total of 44 adult CF patients (17 female) mean age
25.8 years, range 18−41 years were assessed. BIA was performed using whole
body impedance with the Bodysat 1500, (Bodystat Ltd). FFM was calculated using
the manufacturer’s software. Outcome measures investigated were; FEV1, body
mass index (BMI), modiﬁed performance score and number of annual pulmonary
exacerbations.
Results: FFM values did not correlate with age, but were signiﬁcantly greater in
male than in female patients; mean FFM (SEM) 82.6 (1.0) for male vs. 72.55 (1.3)
for female; P< 0.0001. There was a weak correlation between FFM and BMI
in male (r = 0.39, P< 0.05) and for female (r = 0.45) although the latter did not
reach statistical signiﬁcance (P = 0.07). There was no correlation between FFM and
number of annual pulmonary exacerbations, FEV1 or with modiﬁed performance
score.
Conclusion: In this cohort of adult CF patients FFM correlated with BMI in male
patients but not in female patients. It did not correlate with any other recognised
outcome measure. We question the added value of this method to the routine
evaluation of CF patients.
229 Hand grip strength values correlate with recognised outcome
measures in a cohort of adult CF patients
J. Al Siaidi, N.A. Jarad. Adult CF Centre, Bristol Royal Inﬁrmary, Bristol, BS2
8HW, United Kingdom
Background: Hand grip strength (HGS) is a method used to assess the function of
peripheral muscle. Its values are indicative of global muscle power and nutritional
state. Correlation between HGS and recognised outcome measures in adult CF
patients has not previously been investigated.
Patients and methods: HGS was measured in 41 CF patients (14 female); mean
age 24 years, range 18−41years. Their mean (SD) FEV1 was 69 (26.7) percent
of predicted values. HGS was measured using a hand grip dynamometer (GRIP-
DTKK 5101; Takei). Reduced HGS was determined to be <85% of normal, for age
and gender, (Goode et al and Klidjian et al). Fat free mass (FFM) was estimated
using bioelectrical impedance analysis. Outcome measures used for correlations
were; body mass index (BMI), FEV1, number of pulmonary exacerbation within
the pervious year and modiﬁed performance score.
Results: Percentage of predicted FEV1 was signiﬁcantly lower in patients with
reduced HGS; mean ± (SEM) was 53.00±(6.9), compared to patients with normal
values; 76.4±(5.07), P = 0.01. Similarly the number of annual pulmonary exacerba-
tions were greater, 2.8±(0.69) in those with reduced HGS compared to those with
normal values 2.3±(0.46). The modiﬁed global performance score was signiﬁcantly
lower when HGS was reduced than when values were normal, 14±1.0 (for reduced),
16.8±0.5 (for normal), P = 0.02. The values of HGS correlated with percentage of
FFM (r = +0.44, P = 0.005) and with BMI (r = 0.43, P< 0.007).
Conclusion: Hand grip strength is a simple method that correlates with recognised
outcome measures in adult CF patients. It can be used in the evaluation of nutritional
status.
